CD14 and rheumatoid arthritis: Although other publications report contrasting findings of either an increased [38-40] or a decreased [41] percentage of CD14+CD16+ monocytes in inflammatory compared with healthy conditions, our experiments did not identify differences in these monocyte subsets between SpA and RA patients and healthy donors.